AMRN Amarin Corporation plc
Amarin Corporation plc (AMRN) is expected to report earnings on January 27, 2027, before the market open. The consensus earnings estimate is a loss of $0.31 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -6.7% since its last earnings release on October 28, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company with expertise in lipid science. The Company is engaged in commercialization and development of therapeutics to improve cardiovascular health.
Sector
Healthcare
Industry
Drug Delivery
Charts powered in part by Lightweight Charts™ by TradingView.